{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:56:37Z","timestamp":1790312197373,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":3144,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1074\/jbc.m111.280016","type":"journal-article","created":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T04:21:36Z","timestamp":1323836496000},"page":"4275-4287","source":"Crossref","is-referenced-by-count":99,"title":["Ex Vivo and in Vivo Effects of Isofagomine on Acid \u03b2-Glucosidase Variants and Substrate Levels in Gaucher Disease"],"prefix":"10.1016","volume":"287","author":[{"given":"Ying","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Hai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wujuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Hamler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth D.R.","family":"Setchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M111.280016_bib1","author":"Grabowski","year":"2010"},{"key":"10.1074\/jbc.M111.280016_bib2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1086\/302925","article-title":"Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease","volume":"66","author":"Koprivica","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1074\/jbc.M111.280016_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0888-7543(89)90319-4","article-title":"The human glucocerebrosidase gene and pseudogene: structure and evolution","volume":"4","author":"Horowitz","year":"1989","journal-title":"Genomics"},{"key":"10.1074\/jbc.M111.280016_bib4","first-page":"33","article-title":"Phenotypic manifestations of Gaucher disease: clinical features in 48 biochemically verified type 1 patients and comment on type 2 patients","volume":"95","author":"Kolodny","year":"1982","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1074\/jbc.M111.280016_bib5","first-page":"176","article-title":"Infantile Gaucher's disease: electron microscopic and histochemical studies of a cerebral biopsy","volume":"26","author":"Volk","year":"1967","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1074\/jbc.M111.280016_bib6","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1074\/jbc.M111.280016_bib7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/oxfordjournals.jbchem.a122457","article-title":"Intracellular transport of acid \u03b1-glucosidase in human fibroblasts: evidence for involvement of phosphomannosyl receptor-independent system","volume":"104","author":"Tsuji","year":"1988","journal-title":"J. Biochem."},{"key":"10.1074\/jbc.M111.280016_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0378-1119(90)90264-R","article-title":"Prevalent and rare mutations among Gaucher patients","volume":"96","author":"Eyal","year":"1990","journal-title":"Gene"},{"key":"10.1074\/jbc.M111.280016_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/bmme.1996.0077","article-title":"The glucocerebrosidase D409H mutation in Gaucher disease","volume":"59","author":"Pasmanik-Chor","year":"1996","journal-title":"Biochem. Mol. Med."},{"key":"10.1074\/jbc.M111.280016_bib10","first-page":"212","article-title":"Gaucher disease: molecular heterogeneity and phenotype-genotype correlations","volume":"45","author":"Theophilus","year":"1989","journal-title":"Am. J. Hum. Genet."},{"key":"10.1074\/jbc.M111.280016_bib11","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid \u03b2-glucosidase deficiency: the defect in Gaucher disease","volume":"163","author":"Xu","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1074\/jbc.M111.280016_bib12","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1073\/pnas.95.5.2503","article-title":"Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure","volume":"95","author":"Liu","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.280016_bib13","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1194\/jlr.M500202-JLR200","article-title":"Gaucher disease mouse models: point mutations at the acid \u03b2-glucosidase locus combined with low-level prosaposin expression lead to disease variants","volume":"46","author":"Sun","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1074\/jbc.M111.280016_bib14","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1194\/jlr.M600239-JLR200","article-title":"Conditional expression of human acid \u03b2-glucosidase improves the visceral phenotype in a Gaucher disease mouse model","volume":"47","author":"Sun","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1074\/jbc.M111.280016_bib15","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.22400","article-title":"Acid \u03b2-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter \u03b1-synuclein processing","volume":"69","author":"Cullen","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1074\/jbc.M111.280016_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/mgme.2000.3035","article-title":"Fate and sorting of acid \u03b2-glucosidase in transgenic mammalian cells","volume":"70","author":"Leonova","year":"2000","journal-title":"Mol. Genet. Metab."},{"key":"10.1074\/jbc.M111.280016_bib17","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1111\/j.1742-4658.2007.06042.x","article-title":"Pharmacologic chaperoning as a strategy to treat Gaucher disease","volume":"274","author":"Yu","year":"2007","journal-title":"FEBS J."},{"key":"10.1074\/jbc.M111.280016_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/4801","article-title":"Accelerated transport and maturation of lysosomal \u03b1-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor","volume":"5","author":"Fan","year":"1999","journal-title":"Nat. Med."},{"key":"10.1074\/jbc.M111.280016_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nchembio850","article-title":"Structure of acid \u03b2-glucosidase with pharmacological chaperone provides insight into Gaucher disease","volume":"3","author":"Lieberman","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1074\/jbc.M111.280016_bib20","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1073\/pnas.0605928103","article-title":"The iminosugar isofagomine increases the activity of N370S mutant acid \u03b2-glucosidase in Gaucher fibroblasts by several mechanisms","volume":"103","author":"Steet","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.280016_bib21","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1742-4658.2010.07588.x","article-title":"The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of \u03b2-glucosidase","volume":"277","author":"Khanna","year":"2010","journal-title":"FEBS J."},{"key":"10.1074\/jbc.M111.280016_bib22","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1074\/jbc.M511110200","article-title":"Analyses of variant acid \u03b2-glucosidases: effects of Gaucher disease mutations","volume":"281","author":"Liou","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.280016_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/abio.1997.2143","article-title":"Successive isolation and separation of the major lipid fractions including gangliosides from single biological samples","volume":"249","author":"Dreyfus","year":"1997","journal-title":"Anal. Biochem."},{"key":"10.1074\/jbc.M111.280016_bib24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1074\/jbc.M110.150433","article-title":"X-ray and biochemical analysis of N370S mutant human acid \u03b2-glucosidase","volume":"286","author":"Wei","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.280016_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1203\/00006450-199602000-00021","article-title":"Turnover and distribution of intravenously administered mannose-terminated human acid \u03b2-glucosidase in murine and human tissues","volume":"39","author":"Xu","year":"1996","journal-title":"Pediatr. Res."},{"key":"10.1074\/jbc.M111.280016_bib26","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S \u03b2-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.280016_bib27","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1111\/j.1742-4658.2006.05410.x","article-title":"Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients","volume":"273","author":"Chang","year":"2006","journal-title":"FEBS J."},{"key":"10.1074\/jbc.M111.280016_bib28","doi-asserted-by":"crossref","first-page":"e19037","DOI":"10.1371\/journal.pone.0019037","article-title":"Isofagomine in vivo effects in a neuronopathic Gaucher disease mouse","volume":"6","author":"Sun","year":"2011","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M111.280016_bib29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1124\/jpet.108.149054","article-title":"Preclinical efficacy and safety of 1-deoxygalactonojirimycin in mice for Fabry disease","volume":"328","author":"Ishii","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1074\/jbc.M111.280016_bib30","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.1021\/ja001762x","article-title":"A large difference in the thermodynamics of binding of isofagomine and 1-deoxynojirimycin to \u03b2-glucosidase","volume":"122","author":"B\u00fclow","year":"2000","journal-title":"J. Am. Chem. Soc."},{"key":"10.1074\/jbc.M111.280016_bib31","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/bi9002265","article-title":"Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability","volume":"48","author":"Lieberman","year":"2009","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M111.280016_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1432-1033.1985.tb08655.x","article-title":"Characterization of human glucosylsphingosine glucosyl hydrolase and comparison with glucosylceramidase","volume":"146","author":"Vaccaro","year":"1985","journal-title":"Eur. J. Biochem."},{"key":"10.1074\/jbc.M111.280016_bib33","doi-asserted-by":"crossref","first-page":"e10750","DOI":"10.1371\/journal.pone.0010750","article-title":"Comparative therapeutic effects of velaglucerase alfa and imiglucerase in a Gaucher disease mouse model","volume":"5","author":"Xu","year":"2010","journal-title":"PLoS One"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820482328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820482328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M111.280016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T17:11:46Z","timestamp":1641316306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820482328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0021925820482328"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m111.280016","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}